Parry S, Denehy L, Berney S, Browning L
Department of Physiotherapy, School of Health Sciences, The University of Melbourne, Alan Gilbert Building, Level 7, 161 Barry Street, Carlton 3053, VIC, Australia; Department of Physiotherapy, Austin Health, Heidelberg 3084, VIC, Australia.
Department of Physiotherapy, School of Health Sciences, The University of Melbourne, Alan Gilbert Building, Level 7, 161 Barry Street, Carlton 3053, VIC, Australia.
Physiotherapy. 2014 Mar;100(1):47-53. doi: 10.1016/j.physio.2013.05.002. Epub 2013 Aug 16.
(1) To determine the ability of the Melbourne risk prediction tool to predict a pulmonary complication as defined by the Melbourne Group Scale in a medically defined high-risk upper abdominal surgery population during the postoperative period; (2) to identify the incidence of postoperative pulmonary complications; and (3) to examine the risk factors for postoperative pulmonary complications in this high-risk population.
Observational cohort study.
Tertiary Australian referral centre.
50 individuals who underwent medically defined high-risk upper abdominal surgery. Presence of postoperative pulmonary complications was screened daily for seven days using the Melbourne Group Scale (Version 2). Postoperative pulmonary risk prediction was calculated according to the Melbourne risk prediction tool.
(1) Melbourne risk prediction tool; and (2) the incidence of postoperative pulmonary complications.
Sixty-six percent (33/50) underwent hepatobiliary or upper gastrointestinal surgery. Mean (SD) anaesthetic duration was 377.8 (165.5) minutes. The risk prediction tool classified 84% (42/50) as high risk. Overall postoperative pulmonary complication incidence was 42% (21/50). The tool was 91% sensitive and 21% specific with a 50% chance of correct classification.
This is the first study to externally validate the Melbourne risk prediction tool in an independent medically defined high-risk population. There was a higher incidence of pulmonary complications postoperatively observed compared to that previously reported. Results demonstrated poor validity of the tool in a population already defined medically as high risk and when applied postoperatively. This observational study has identified several important points to consider in future trials.
(1)确定墨尔本风险预测工具在医学定义的高风险上腹部手术人群术后预测墨尔本小组量表所定义的肺部并发症的能力;(2)确定术后肺部并发症的发生率;(3)研究该高风险人群术后肺部并发症的危险因素。
观察性队列研究。
澳大利亚三级转诊中心。
50例接受医学定义的高风险上腹部手术的患者。使用墨尔本小组量表(第2版)在术后7天每天筛查是否存在术后肺部并发症。根据墨尔本风险预测工具计算术后肺部风险预测。
(1)墨尔本风险预测工具;(2)术后肺部并发症的发生率。
66%(33/50)的患者接受了肝胆或上消化道手术。平均(标准差)麻醉持续时间为377.8(165.5)分钟。风险预测工具将84%(42/50)的患者分类为高风险。总体术后肺部并发症发生率为42%(21/50)。该工具的敏感性为91%,特异性为21%,正确分类的概率为50%。
这是第一项在独立的医学定义高风险人群中对墨尔本风险预测工具进行外部验证的研究。与先前报道相比,观察到术后肺部并发症的发生率更高。结果表明,该工具在已被医学定义为高风险的人群中以及术后应用时有效性较差。这项观察性研究确定了未来试验中需要考虑的几个要点。